NovantaNOVT
NOVT
0
Funds holding %
of 7,390 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
69% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 29
6% more funds holding
Funds holding: 284 [Q3] → 300 (+16) [Q4]
0.01% more ownership
Funds ownership: 99.19% [Q3] → 99.2% (+0.01%) [Q4]
15% less capital invested
Capital invested by funds: $6.37B [Q3] → $5.44B (-$930M) [Q4]
18% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 115
67% less call options, than puts
Call options by funds: $1.97M | Put options by funds: $5.9M
100% less funds holding in top 10
Funds holding in top 10: 2 [Q3] → 0 (-2) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$160
24%
upside
Avg. target
$160
24%
upside
High target
$160
24%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
Baird Robert Mason 38% 1-year accuracy 5 / 13 met price target | 24%upside $160 | Neutral Maintained | 3 Mar 2025 |
Financial journalist opinion
Neutral
Seeking Alpha
1 month ago
Novanta Inc. (NOVT) Q4 2024 Earnings Call Transcript
Novanta Inc. (NOVT) Q4 2024 Earnings Call Transcript

Positive
Zacks Investment Research
1 month ago
Novanta (NOVT) Q4 Earnings Beat Estimates
Novanta (NOVT) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.63 per share a year ago.

Neutral
Business Wire
1 month ago
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2024. Financial Highlights Three Months Ended December 31, Year Ended December 31, (In millions, except per share amounts) 2024 2023 2024 2023 GAAP Revenue $ 238.1 $ 211.6 $ 949.2 $ 881.7 O.

Neutral
Business Wire
2 months ago
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 25, 2025
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2024 results on Tuesday, February 25, 2025. The Company will host a conference call on Tuesday, February 25, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can.

Neutral
Business Wire
3 months ago
Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that management will be participating at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025, which is being held virtually. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equip.

Neutral
Business Wire
3 months ago
Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025, in San Francisco, California. About Novanta Novanta is a leading global supplier of core technology solu.

Neutral
Seeking Alpha
4 months ago
Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript
Novanta Inc. (NASDAQ:NOVT ) Q3 2024 Results Conference Call November 5, 2024 10:00 AM ET Company Participants Ray Nash - Corporate Finance Leader Matthijs Glastra - Chair and Chief Executive Officer Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities Brian Drab - William Blair Rob Mason - Baird Operator Good morning. My name is Gary, and I will be your conference operator today.

Negative
Zacks Investment Research
4 months ago
Novanta (NOVT) Q3 Earnings Miss Estimates
Novanta (NOVT) came out with quarterly earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.85 per share a year ago.

Neutral
Business Wire
4 months ago
Novanta Announces Financial Results for the Third Quarter 2024
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2024. Financial Highlights Three Months Ended (In millions, except per share amounts) September 27, September 29, 2024 2023 GAAP Revenue $ 244.4 $ 221.5 Operating Income $ 32.6 $ 30.3 Net Income $ 19.2 $ 21.2 Diluted EPS.

Neutral
Business Wire
5 months ago
Novanta to Present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024
BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024, in Chicago, Illinois. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original.

Charts implemented using Lightweight Charts™